«The discovery of an alternative binding site and the AAPs represents a significant step towards the identification of a novel RNAP inhibitor that would behave
like rifampin but be devoid of any pre-existing resistance,» said Nader Fotouhi, Chief Scientific Officer at the Global Alliance for TB Drug Development, a not - for - profit organization dedicated to finding faster - acting and affordable drug regimens to fight drug sensitive and resistant tuberculosis.
Not exact matches
But it could also withstand a wide variety of antibiotics
like ampicillin, chloramphenicol, tetracycline,
rifampin, and even ciprofloxacin, a heavy - hitter used as a last resort against resistant Salmonella.